Serenity 6 Panel Drug Test Cup with BUP, OXY and OPI/300

Serenity 6 Panel Drug Test Cup with Buprenorphine and Oxycodone

The Serenity 6 Panel Drug Test Cup combines urine collection and preliminary screening for amphetamine, buprenorphine, benzodiazepines, cocaine, opiates and oxycodone in one integrated device.

This configuration is different from a conventional six-panel drug test because it includes dedicated BUP and OXY panels and does not include THC. It may be considered by professional testing programs that need targeted opioid and prescription-drug screening without marijuana testing.

Preliminary results are generally available in approximately five minutes when the cup is stored, collected, activated and interpreted according to the manufacturer’s instructions.

What Does This Serenity 6 Panel Cup Test For?

Cutoff levels identify the concentrations used by the device for preliminary screening. They do not describe how long a substance remains detectable.

Detection windows vary according to the substance, dose, frequency of use, metabolism, hydration, specimen concentration and time since exposure. Review our educational guides to drug test cutoff levels and urine drug detection times for additional information.

Why This Configuration Includes BUP and OXY

A general opiate panel should not be assumed to detect every opioid or medication. This cup includes separate panels for three related but distinct screening targets.

Buprenorphine

The BUP panel screens for buprenorphine at 10 ng/mL. Buprenorphine may be present in medications used for pain management or opioid-use-disorder treatment. A screening result does not establish whether use was prescribed, appropriate or unauthorized.

Oxycodone

The OXY panel screens for oxycodone at 100 ng/mL. Oxycodone may not be adequately represented by every general opiate assay, which is why programs requiring oxycodone screening should choose a configuration that explicitly includes OXY.

Opiates

The OPI/MOR panel screens at 300 ng/mL. It should not be interpreted as universal screening for every natural, semisynthetic or synthetic opioid.

This combination gives purchasers separate preliminary results for BUP, OPI and OXY rather than relying on one general opioid-related panel.

No THC Configuration

This product does not include a THC panel.

A no-THC configuration may be useful when an organization’s written testing program requires amphetamine, buprenorphine, benzodiazepines, cocaine, opiates and oxycodone but does not require marijuana screening.

The absence of THC should be prominently stated near the product title and panel list so buyers do not assume that every six-panel cup includes marijuana.

If THC testing is required, compare all available 6 panel drug test cups and select a configuration that explicitly lists THC.

Who May Use This Six-Panel Cup?

Subject to its regulatory documentation and the purchaser’s testing policies, this configuration may be considered by:

• Treatment and recovery programs
• Medication-monitoring programs
• Pain-management organizations
• Clinics and physician offices
• Occupational-health providers
• Probation and correctional programs
• Drug courts
• Mobile drug-testing services
• Other professional testing organizations

A screening result cannot determine whether a detected substance was prescribed or used appropriately. Medication history, laboratory confirmation and professional review may be needed before a final determination.

Serenity Cup Features

The integrated Serenity cup format helps simplify urine collection and preliminary screening by keeping the specimen and testing panels in one device.

Product features include:

• Six integrated screening panels
• Dedicated BUP and OXY tests
• OPI screening at 300 ng/mL
• No THC panel
• Leak-resistant screw-on lid
• Integrated temperature strip
• Peel-off or covered results area
• Approximately five-minute results
• Single-use disposable format
• Quantity-based pricing

Confirm the exact cup capacity against SKU SM-CDOA-265 before adding a volume measurement to the page.

Understanding Preliminary Results

This cup produces preliminary qualitative screening results.

A negative result means the targeted drug or metabolite was not detected at or above the panel’s cutoff concentration. It does not prove that the substance is entirely absent.

A presumptive non-negative result does not establish:

• Whether the substance was prescribed
• Whether medication was taken correctly
• The amount consumed
• The time of consumption
• Current impairment
• A final laboratory-confirmed positive

Send presumptive non-negative specimens for confirmation using an appropriate analytical method, such as GC-MS or LC-MS/MS, before making a final clinical, employment or legal determination.

CLIA-Waived and FDA-Cleared Status

The existing page identifies this product as CLIA waived and FDA cleared. Verify those claims against the exact manufacturer documentation and SKU before publishing the revised page.

Regulatory status applies to a specific product and configuration. It should not be inferred solely because another Serenity cup has the same number of panels or a similar appearance.

CLIA-waived status also does not automatically make a cup suitable for every workplace, clinical, state-regulated or federally regulated testing program.

Buyers comparing regulated-use products can review our CLIA-waived drug test cups guide.

Is This a DOT Drug Test Cup?

This six-panel instant cup should not be marketed as a replacement for DOT-regulated drug testing.

DOT testing follows a defined laboratory-based five-panel program and procedures established under 49 CFR Part 40. The presence of AMP, COC and OPI-related panels does not make this six-panel configuration a DOT test.

Organizations conducting both DOT and non-DOT testing should keep the programs and documentation separate.

Compare Other 6 Panel Configurations

Choose this Serenity configuration when your program requires:

• Buprenorphine
• Oxycodone
• Opiates at 300 ng/mL
• Amphetamine
• Benzodiazepines
• Cocaine
• No THC

Buyers needing THC, methamphetamine and an OPI/2000 panel can compare the economy 6 panel urine drug test cup.

Programs requiring pH, specific gravity and creatinine should review the 6 panel drug test with adulteration testing.

For fentanyl, EtG, kratom, K2 and xylazine, consider the 6 panel specialty drug test cup.

Bulk Serenity 6 Panel Drug Test Cups

DrugTestingCup.com offers quantity-based pricing for clinics, treatment organizations, correctional programs, distributors and other high-volume purchasers.

Available purchasing benefits include:

• Volume discounts
• Free shipping on orders of 100 or more cups
• Same-day shipping on qualifying orders placed before 3:00 p.m. Eastern Time
• Recurring-order savings
• Distributor and large-order pricing
• Help comparing panel configurations
• Access to product documentation

Organizations needing recurring inventory can also review our wholesale drug testing supplies or contact us for current availability and pricing.

Product Specifications

Frequently Asked Questions

What drugs does this Serenity 6 panel cup test for?

It screens for amphetamine, buprenorphine, benzodiazepines, cocaine metabolite, opiates and oxycodone.

Does this six-panel cup test for THC?

No. This configuration does not include a THC panel. Buyers requiring marijuana screening should choose a different six-panel configuration that explicitly lists THC.

Does the OPI panel detect buprenorphine?

Buprenorphine should not be assumed to appear on a general opiate panel. This cup includes a separate BUP panel at 10 ng/mL.

Does the OPI panel detect oxycodone?

A general opiate panel may not provide the required oxycodone screening. This cup includes a dedicated OXY panel at 100 ng/mL.

What is the opiate cutoff?

The OPI/MOR panel uses a cutoff concentration of 300 ng/mL. Verify this value against the current insert for SKU SM-CDOA-265.

Is this cup CLIA waived and FDA cleared?

The current product page identifies it as CLIA waived and FDA cleared. Verify both claims using the exact manufacturer documentation and SKU before relying on them.

Does a non-negative BUP result prove unauthorized Suboxone use?

No. A screening result does not establish which medication was taken, whether it was prescribed or whether it was used appropriately. Laboratory confirmation and professional review may be required.

Are non-negative results final?

No. All non-negative screening results are preliminary and should be confirmed using an appropriate laboratory method before a final determination is made.